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disease progression. Much effort continues to be directed to devel-
oping and testing interventions that lower KAM with the goal of
modifying disease course in knee OA. To date, there are only two
longitudinal studies evaluating the relationship between KAM and
disease progression. By incorporating both the load magnitude and
duration, KAM impulse may provide a cumulative measure of the
external adduction moment sustained during each step of walking.
Studies in recent years suggest that a reduction in KAM may be
accompanied by a deleterious increase in the external knee ﬂexion
moment (KFM). We hypothesized that in persons with knee OA,
greater baseline peak KAM and KAM impulse (normalized to body
weight and height) during the stance phase of gait are each associated
with baseline-to-2-year worsening of medial tibiofemoral cartilage
damage and bone marrow lesions, adjusting for gait speed, age,
gender, disease severity, and KFM.
Methods: Participants all had knee OA deﬁned by osteophyte presence
in at least one knee at baseline. Three-dimensional knee kinematics and
kinetics during ambulation on a 35 x 4 foot walkway were captured at a
rate of 120 Hz, using external passive reﬂective markers, an 8-camera
Digital Real-Time Eagle motion analysis system, and 6 AMTI force plates.
Inverse dynamics were used to compute peak KAM, KAM impulse, and
peak KFM during stance. Participants underwent 3.0TMRI of both knees
at baseline and two years later using double oblique coronal and axial
FLASH sequences, coronal T1-weighted spin-echo (SE), and sagittal,
coronal and axial fat-suppressed turbo spin echo sequences. Cartilage
damage and bone marrow lesion baseline-to-2-year progression wereTable 1
Mean (SD) of KAM and KAM impulse in knees with and without cartilage damage progression and bone marrow lesion progression (n ¼ 391 knees from 204 persons)
Cartilage damage progression at 2-year follow-up Bone marrow lesion progression at 2-year follow-up
Medial tibiofemoral
compartment 61/391
(15.6%)#
Medial femoral
surface 48/391
(12.3%)
Medial tibial
surface 29/391
(7.4%)
Medial tibiofemoral
compartment 87/391
(22.3%)
Medial femoral
surface 53/391
(13,6%)
Medial tibial
surface 48/391
(12.3%)
KAM (% body wt*ht) Knees without
progression
1.66 (0.87) 1.67 (0.86) 1.65 (0.86) 1.59 (0.86) 1.65 (0.87) 1.60 (0.85)
Knees with
progression
1.70 (0.77) 1.68 (0.81) 1.83 (0.76) 1.92 (0.77) 1.77 (0.73) 2.15 (0.71)
KAM impulse
(s*% body wt*ht)
Knees without
progression
0.60 (0.43) 0.60 (0.43) 0.59 (0.43) 0.55 (0.42) 0.59 (0.44) 0.56 (0.42)
Knees with
progression
0.64 (0.50) 0.64 (0.51) 0.73 (0.51) 0.79 (0.47) 0.70 (0.43) 0.92 (0.45)
Table 2
Adjusted odds ratio (95% CI) for medial tibiofemoral cartilage damage progression and bone marrow lesion progression outcomes (n ¼ 391 knees from 204 persons)
Baseline predictor
variable
Co-variables included
in the adjusted models
Cartilage damage progression at 2-year follow-up Bone marrow lesion progression at 2-year follow-up
Medial tibiofemoral
compartment 61/391
(15.6%)
Medial femoral
surface 48/391
(12.3%)
Medial tibial
surface 29/391
(7.4%)
Medial tibiofemoral
compartment 87/391
(22.3%)
Medial femoral
surface 53/391
(13.6%)
Medial tibial
surface 48/391
(12.3%)
KAM (% body wt*ht) Gait speed, age, and
gender
1.09 (0.80, 1.47) 1.05 (0.75, 1.48) 1.33 (0.96, 1.85) 1.55 (0.98, 2.43) 1.17 (0.89, 1.53) 1.93 (1.0061, 3.71)
Gait speed, age, gender,
and K/L grade
0.98 (0.71, 1.35) 0.96 (0.67, 1.38) 1.21 (0.85, 1.71) 1.32 (0.96, 1.80) 1.06 (0.82, 1.37) 1.55 (1.06, 2.25)
Gait, speed, age, gender,
K/L grade, and KFM
0.98 (0.71, 1,36) 0.96 (0.67, 1.37) 1.21 (0.85, 1.73) 1.28 (0.92, 1.79) 1.01 (0.78, 1.32) 1.58 (1.08, 2.31)
KAM impulse
(s*% body wt*ht)
Gait speed, age, and
gender
1.18 (0.57, 2.47) 1.11 (0.50, 2.46) 2.09 (0.71, 6.11) 3.41 (1.58, 7.37) 1.71 (0.94, 3.11) 6.76 (2.96, 15.42)
Gait speed, age, gender,
and K/L grade
0.98 (0.53, 1.82) 0.96 (0.49, 1.91) 1.52 (0.61, 3.78) 2.34 (1.18, 4.66) 1.34 (0.81, 2.19) 3.63 (1.61, 8.20)
Gait, speed, age, gender,
K/L grade, and KFM
0.99 (0.54, 1.82) 0.96 (0.49, 1.87) 1.52 (0.63, 3.69) 2.28 (1.15, 4.54) 1.28 (0.78, 2.12) 3.67 (1.60, 8.41)deﬁned as worsening of WORMS score in the medial tibiofemoral
compartment, the medial femoral weight-bearing surface, and the
medial tibial surface. To assess the relationship between baseline peak
KAM and KAM impulse and subsequent medial cartilage damage and
bone marrow lesion progression, we used logistic regression with
generalized estimating equations (GEE) to account for the correlation
between the 2 limbs of each individual, ﬁrst adjusting for gait speed,
age, and gender; then further adjusting for disease severity (using K/Lradiographic grade); and ﬁnally also adjusting for KFM. Results are
reported as odds ratios (ORs) and 95% conﬁdence intervals (CIs).
Results: The study sample consisted of 391 knees from 204 persons:
mean age 64.2 years (SD 9.9); BMI 28.4 kg/m2 (5.7); 156 (76.5%)
women. Mean peak KAM and KAM impulse were 1.67 (SD 0.85) % body
weight*height and 0.60 (0.44) seconds*% body weight*height, respec-
tively. Table 1 summarizes KAM and KAM impulse data in knees with
and without disease progression. Table 2 shows that greater baseline
KAM was associated with increased odds of 2-year bone marrow lesion
progression at the medial tibial surface, and that greater baseline KAM
impulse was associated with increased odds of 2-year bone marrow
lesion progression in the medial tibiofemoral compartment and at the
medial tibial surface. With further adjustment for disease severity,
these relationships were attenuated but remained statistically sig-
niﬁcant. The adjusted OR was minimally altered by further adjustment
for baseline KFM.
Conclusions: Higher baseline KAM and KAM impulse were not asso-
ciated with 2-year medial tibiofemoral cartilage damage progression
but were each associated with increased odds of medial bone marrow
lesion progression, particularly at the tibial surface. In the medial
tibiofemoral compartment as a whole, KAM impulse, but not KAM, was
associated with bone marrow lesion progression. KFM did not appear to
inﬂuence the relationship between KAM and tissue damage pro-
gression. While bone marrow lesion progression may be a harbinger of
future cartilage damage, there was no evidence of a relationship
between KAM or KAM impulse and cartilage damage by 2-year follow-
up.69
THREE-DIMENSIONAL LOWER LIMB BIOMECHANICS DURING GAIT
PREDICT PROGRESSION TO TOTAL KNEE ARTHROPLASTY
G. Hatﬁeld, J. Astephen Wilson, M. Dunbar, W. Stanish,
C. Hubley-Kozey. Dalhousie Univ., Halifax, NS, Canada
Purpose: Frontal plane lower limb gait biomechanics are predictive of
knee osteoarthritis (OA) structural progression, and frontal and
Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56S46sagittal plane features are different at baseline in those that progress
to total knee arthroplasty (TKA) compared to those that do not.
However, no modelling using gait biomechanics has predicted pro-
gression to TKA (a clear endpoint that includes structure and symp-
tom aspects of progression), and structural progression prediction
models only included individual frontal plane features. This study
determined: i) how well individual three-dimensional (3D) lower
limb biomechanical gait features discriminated between those who
progress to TKA and those that do not, ii) if a multivariate model
improved discrimination ability, and iii) how well gait biomechanical
features that best discriminated between groups predicted pro-
gression to TKA.
Methods: 54 knee OA patients underwent baseline gait analysis
where 3D lower limb motion and ground reaction forces were
recorded. 3D hip, knee, and ankle angles were expressed in the joint
coordinate system. External moments were calculated using inverse
dynamics and amplitude-normalized to body mass (Nm/kg). Wave-
form shape and magnitude features were extracted using Principal
Component Analysis (PCA), and waveforms were scored based on
how closely they matched an extracted pattern. PC scores were used
in statistical testing. Knee adduction moment (KAM) peak (Nm/kg)
and impulse (Nm/kg*s) were also calculated. 5-8 years later, 26
patients reported having TKA. Receiver operating characteristic
(ROC) curve analysis determined discriminative abilities of individual
gait variables. Stepwise discrimination analysis determined which
multivariate combinations discriminated between groups. Discrim-
inant function scores were calculated based on multivariate models,
and used as input for additional ROC curve analyses to determine
which multivariate model best discriminated between groups
(highest area under ROC curve). Logistic regression analysis deter-
mined predictive ability of the multivariate model with the highest
discrimination.
Results: There were no signiﬁcant baseline differences in demographic,
clinical and spatiotemporal gait characteristics, but 3D hip, knee, and
ankle gait features signiﬁcantly discriminated between TKA and no-TKA
groups. KAM impulse resulted in the best univariate discrimination
based on area under the ROC curve (AUC¼0.79) with overall shape and
magnitude of KAM (KAMPC1) having the second-highest AUC. Multi-
variate models had higher AUCs ranging from 0.80-0.85. In all multi-
variate models, overall KAM magnitude (impulse or KAMPC1) was the
most dominant variable for progression to TKA. The multivariate model
with the highest discrimination and correct classiﬁcation ability
(AUC¼0.85, 74.1% correct classiﬁcation rate) contained KAMPC1, dif-
ference between the early stance knee ﬂexion and late stance knee
extension moments (KFMPC2), and stance ankle dorsiﬂexion moment
(AFMPC4). Higher overall KAM magnitude, decreased knee ﬂexion to
extension moment difference, and decreased stance dorsiﬂexion
moment were associated with progression to TKA. This model had an
odds ratio of 5.7.
Conclusions: Non-frontal plane moments were predictive of pro-
gression to TKA. Multivariate models were better able to discriminate
between groups than univariate models, with the best model capturing
overall magnitude of loading (KAMPC1), and inability to unload the
knee (KFMPC2, AFMPC4). This suggests that higher overall cartilage
loading along with sustained cartilage loading were predictive of pro-
gression to TKA. These ﬁndings are consistent with animal models
showing that sustained loading can lead to cartilage degradation and
upregulation of inﬂammatory chemicals linked to knee pain. Sustained
cartilage loading has not previously been identiﬁed as a risk factor for
progression, and can be a new target in the development and evaluation
of conservative interventions.
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ESTABLISHMENT OF REFERENCE INTERVALS FOR OSTEOARTHRITIS
RELATED BIOMARKERS – THE FNIH/OARSI OA BIOMARKERS
CONSORTIUM
V. Byers Kraus y, D.E. Hargrove z, D.J. Hunter x, J.B. Renner k,
J.M. Jordan k. yDuke Univ., Durham, NC, USA; z LabCorp Clinical Trials, San
Leandro, CA, USA; xUniv. of Sydney, Sydney, Australia; kUniv. of North
Carolina, Chapel Hill, NC, USA
Purpose: A Reference Interval (RI) is the central 95% range - or normal
range - for endogenous analytes of a healthy person. Traditionally,
reference ranges for biomarkers are established using commercially
purchased "normals" including "normal" blood donors. Such "normals"are rarely adequate controls for Osteoarthritis (OA) studies as they are
rarely if ever ascertained for OA status. The objective of this ancillary
study was to establish reference intervals for the FNIH/OARSI panel of
OA related biochemical biomarkers using biospecimens from strin-
gently phenotyped age appropriate controls. We hypothesized that the
reference interval ranges for these ’super controls’ will facilitate future
formal FDA qualiﬁcation of the FNIH/OARSI OA-related biomarker panel
for OA diagnosis and prognosis and for monitoring the efﬁcacy of
intervention.
Methods: African-American (AA) and Caucasian (C) participants
were selected from the Johnston County Osteoarthritis Project (JoCo
OA) population-based study of OA. From among 1518 participants
with biospecimens and up to 15-years of follow-up radiographic
data, and 412 with biospecimens and radiographic data at one
timepoint, participants were selected who had no radiographic evi-
dence of knee OA (Kellgren-Lawrence [KL] 0 in each knee) or hip OA
(KL 0 or 1 in each hip), and no knee or hip symptoms (pain, aching or
stiffness on most days). Controls further had no radiographic hand
OA (GOGO deﬁnition) or spine radiographic OA (disc narrowing ¼ 0
and anterior osteophytes no greater than 1 at same level). This
yielded a total of N¼129 healthy ’super control’ participants with
minimal or no radiographic burden of disease, two-thirds of whom
had not developed OA in 15 years of observation. Baseline serum and
urine samples from these individuals were analysed in duplicate for
the analytes listed in Table 1. The RIs were determined with the
reference intervals establishment module of EP Evaluator (Data
Innovations) using transformed parametric calculations (Box-Cox
transformation), which transforms the data into a Gaussian model.
The SD ratio (cut-off >1.5) of the EP Evaluator partitioning test was
used to determine if separate reference intervals might be justiﬁed
for population subclasses based on gender or ethnicity (SD ratio
calculated as the larger SD divided by smaller SD of the two sub-
groups, male vs female and AA vs C). Spearman correlations were
used to assess for a correlation between the biomarker concen-
trations and age and body mass index (BMI).
Results: The sample of 129 super controls consisted of 64% women, 34%
African Americans, mean age 59 (SD 8.3, range 45-95) years, mean BMI
29 (SD 5.9) kg/m2. There were no out of range high values. Out of range
low values were set at just below the lower limit of detection of the
assay to compute the RI. The central 95% intervals for the 18 OA-related
biomarkers are provided in Table 1. Based on SD ratio >1.5, separate
reference intervals may be warranted on the basis of gender for sHA,
sMMP-3, sCol2-1NO2, uCTXIb/Cr, uCTXII/Cr, uNTXI/Cr, uCol2-1NO2/Cr
and on the basis of race for sCS846, sCOMP, sMMP3, sCTXI, sCPII, uCTXII/
Cr, and uCol2-1No2/Cr.
Conclusions: The ability to diagnose and prognose OAwith biomarkers
is dependent on a clear understanding of normal reference intervals. For
a highly prevalent and heterogeneous disorder such as OA, the lack of
ascertainment of OA status leads to misclassiﬁcation of controls. These
well-phenotyped controls represent a similar age demographic to that
of the Osteoarthritis Initiative-FNIH main study sample so they should
provide an optimal reference control for the main study. To our
knowledge, no comparable ’super control’ sample has ever been char-
acterized for such an extensive panel of OA-related biomarkers.
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LIPIDS AS MEDIATORS OF CHONDROGENESIS
N. Georgi y, B. Cillero Pastor z, G. Eijkel z, P.C. Periyasamy y, A. Kiss x,
C. van Blitterswijk y, J.N. Post y, R. Heeren z, M. Karperien y. yMIRA Inst.
for BioMed. technology and technical medicine, Enschede, Netherlands;
z FOM Inst. AMOLF, Amsterdam, Netherlands; x FOM Inst. AMOLF,
Amsterdam, Netherlands
Purpose: We have previously demonstrated that cartilage matrix for-
mation is improved in pellet co-cultures of human mesenchymal stro-
mal/stem cells (MSCs) and human primary chondrocytes (hPCs) under
normoxic culture conditions (21%O2). This co-culture effect is attributed
to the MSC speciﬁc expression of FGF-1. Under hypoxic culture con-
ditions (2.5%O2),weobserved that therewas adecrease in chondrogenic
differentiation in co-cultures as compared to the normoxic culturing
conditions. For clinical applications it is plausible that co-transplantation
of MSCs and chondrocytes into the defect results in improved cartilage
repair. Until now it remains unclear how FGF-1 expression is regulated
under the reduced oxygen level normally present in the joint. It has been
underlined that hypoxia (reduced oxygen availability) and expression of
